Xconomy National

Archives

by in

Entry	Author	Date	Location
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers	Erin Kutz	01/27/12	Boston
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race	Luke Timmerman	01/24/12	Boston
Clarus Ventures Adjusts to Unpredictable Biotech World	Luke Timmerman	01/20/12	Boston
A Good News-Bad News Night for Bristol’s Diabetes and Hepatitis Drugs	Arlene Weintraub	01/19/12	New York
The Top 10 Traffic-Getting Stories at Xconomy San Diego	Bruce V. Bigelow	12/28/11	San Diego
Burrill Raises $313M for New Life Sciences Fund	Luke Timmerman	12/19/11	San Francisco
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition	Luke Timmerman	12/15/11	Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500	Luke Timmerman	12/12/11	National
Dendreon Pulls In $125M By Selling Royalty Slice of Merck’s Hepatitis C Drug	Luke Timmerman	12/06/11	Seattle
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News	Erin Kutz	11/11/11	Boston
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News	Bruce V. Bigelow	11/10/11	San Diego
Vertex Stock Drops 17% Over Two Days, As Potent Hep C Rivals Emerge	Luke Timmerman	11/08/11	Boston
TEDMED Walking, FDA Clears Pacira Drug, Zogenix Close to NDA, & More San Diego Life Sciences News	Bruce V. Bigelow	11/03/11	San Diego
Vertex Flips Into the Black for First Time, as Hepatitis C Drug Beats Expectations Again	Luke Timmerman	10/27/11	Boston
Roche Acquires Anadys, Wests Create $100M Fund, Johnson & Johnson Makes Room for 20 Startups, & More San Diego Life Sciences News	Bruce V. Bigelow	10/20/11	San Diego
Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M	Luke Timmerman	10/17/11	San Diego
UW Scores $40M for Biofuels, Cocrystal’s Fight Against HepC, The Women’s Biotech Network, & More Seattle-Area Life Sciences News	Luke Timmerman	09/29/11	Seattle
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C	Luke Timmerman	09/22/11	Seattle
The Immunex Impact, Calypso Gets Acquired, Women in Bio’s Kickoff, & More in Seattle-Area Life Sciences News	Luke Timmerman	09/22/11	Seattle
Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With Teva	Luke Timmerman	09/15/11	Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue	Steve Worland	09/06/11	San Diego
Kineta Adds $2.8M Grant	Luke Timmerman	08/16/11	Seattle
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut	Luke Timmerman	07/28/11	Boston
J&J Joins Pharmasset for Hepatitis Study	Arlene Weintraub	07/06/11	New York
Vertex Adds New HepC Drugs for $60M	Luke Timmerman	06/13/11	Boston
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News	Erin Kutz	05/27/11	Boston
Nestlé Acquires Prometheus, Trius Raises $30M in Private Placement, Canaan’s Bloch Discusses Advanced BioHealing Deal, & More San Diego Life Sciences News	Bruce V. Bigelow	05/26/11	San Diego
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug	Luke Timmerman	05/23/11	Boston
Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry	Luke Timmerman	05/17/11	New York
Page 1 of 7	next page »